Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Sutetinib maleate |
Synonyms | |
Therapy Description |
Sutetinib maleate is an EGFR inhibitor with activity against uncommon EGFR mutations, which potentially reduces tumor growth (J Clin Oncol 41, 16_suppl (June 01, 2023) 9131). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Sutetinib maleate | Sutetinib | EGFR Inhibitor (Pan) 62 | Sutetinib maleate is an EGFR inhibitor with activity against uncommon EGFR mutations, which potentially reduces tumor growth (J Clin Oncol 41, 16_suppl (June 01, 2023) 9131). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05168566 | Phase II | Sutetinib maleate | Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer | Recruiting | USA | 1 |
NCT06010329 | Phase II | Sutetinib maleate | A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC | Recruiting | USA | 0 |